EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury

Ying Wang, Li-Feng Ping, Fu-Yan Bai, Xin-Huan Zhang, Guang-Hong Li iD

Immunity, Inflammation and Disease · 2024-03 · 12 (3)

DOI: 10.1002/iid3.1191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 13.03.2024. Verfasst von Ying Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Cardiomyopathies, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Medical as well as Academic Promotion Program of Shandong First Medical University, Natural Science Foundation of Shandong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic cardiomyopathy (DCM) represents a major cause of heart failure and a large medical burden worldwide. This study screened the potentially regulatory targets of DCM and analyzed their roles in high glucose (HG)‐induced cardiomyocyte injury.

Methods

Through GEO database, we obtained rat DCM expression chips and screened differentially expressed genes. Rat cardiomyocytes (H9C2) were induced with HG. 3‐hydroxy‐3‐methylglutarylcoenzyme A synthase 2 (Hmgcs2) and microRNA (miR)‐363‐5p expression patterns in cells were measured by real‐time quantitative polymerase chain reaction or Western blot assay, with the dual‐luciferase assay to analyze their binding relationship. Then, 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2‐H‐tetrazolium bromide assay, lactate dehydrogenase assay, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, enzyme‐linked immunosorbent assay, and various assay kits were applied to evaluate cell viability, cytotoxicity, apoptosis, inflammation responses, and oxidative burden.

Results

Hmgcs2 was the vital hub gene in DCM. Hmgcs2 was upregulated in HG‐induced cardiomyocytes. Hmgcs2 downregulation increased cell viability, decreased TUNEL‐positive cell number, reduced HG‐induced inflammation and oxidative stress. miR‐363‐5p is the upstream miRNA of Hmgcs2. miR‐363‐5p overexpression attenuated HG‐induced cell injury.

Conclusions

Hmgcs2 had the most critical regulatory role in DCM. We for the first time reported that miR‐363‐5p inhibited Hmgcs2 expression, thereby alleviating HG‐induced cardiomyocyte injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic CardiomyopathiesMicroRNAsAnimalsRatsGlucoseInflammationMyocytes, CardiacHydroxymethylglutaryl-CoA Synthase

Stichwörter der Autor:innen

GEO database chipdiabetic cardiomyopathyhigh glucosehmgcs2miR-363-5p

Substanzen

GlucoseMicroRNAshmgcs2 protein, ratHydroxymethylglutaryl-CoA Synthase

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.
  • Department of General Medicine, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.

ORCID-Profile: Guang-Hong Li

Förderung

  • Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism
  • Medical as well as Academic Promotion Program of Shandong First Medical University
  • Natural Science Foundation of Shandong Province of China
  • Higher Educational Science and Technology Program of Shandong Province, China

Zitieren

APA

Wang, Y., Ping, L. F., Bai, F. Y., Zhang, X. H., & Li, G. H. (2024). Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury. Immunity, Inflammation and Disease, 12(3). https://doi.org/10.1002/iid3.1191

Vancouver

Wang Y, Ping LF, Bai FY, Zhang XH, Li GH. Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury. Immunity, Inflammation and Disease. 2024;12(3). doi:10.1002/iid3.1191

BibTeX
@article{Wang2024,
  author = {Wang, Ying and Ping, Li-Feng and Bai, Fu-Yan and Zhang, Xin-Huan and Li, Guang-Hong},
  title = {Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  volume = {12},
  number = {3},
  doi = {10.1002/iid3.1191}
}
Kostenlos starten →